ZDHHC21 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 5.15590015126577E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.90923999999759E-05 |
Normal-vs-Stage2 |
1.382980E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.079510E-02 |
Stage1-vs-Stage2 |
2.589000E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.166600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
8.289000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.50180000049838E-08 |
Normal-vs-AfricanAmerican |
3.433600E-01 |
Normal-vs-Asian |
1.637570E-02 |
Caucasian-vs-AfricanAmerican |
5.461600E-01 |
Caucasian-vs-Asian |
7.828000E-01 |
AfricanAmerican-vs-Asian |
7.456200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.53125999999837E-05 |
Normal-vs-Female |
2.23079999999154E-05 |
Male-vs-Female |
7.203400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.400400E-03 |
Normal-vs-Extreme_Weight |
2.228400E-04 |
Normal-vs-Obese |
1.058250E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.098400E-01 |
Normal_Weight-vs-Obese |
7.134100E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
2.069800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.316000E-01 |
Normal-vs-Age(41-60Yrs) |
3.754100E-04 |
Normal-vs-Age(61-80Yrs) |
4.55340000005133E-06 |
Normal-vs-Age(81-100Yrs) |
1.63700999999961E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.156170E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.240200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.765820E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.390600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.682200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.541800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.607600E-01 |
Normal-vs-Grade 3 |
5.389600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.982400E-01 |
Grade 2-vs-Grade 4 |
5.607600E-01 |
Grade 3-vs-Grade 4 |
5.389600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.53839999966965E-07 |
Normal-vs-N1 |
1.449750E-02 |
N0-vs-N1 |
8.383500E-02 |
|
|